Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery

Pharmaceutical Research

Volumn 18, Issue 11, 2001, Pages 1600-1606

  Woo, B H ^a   Jiang, G ^a   Jo, Y W ^b   DeLuca, P P ^a  

^a University of Kentucky   (United States)

^b Dong A Pharmaceutical Company   (South Korea)

Author keywords

Controlled release; Hydroxyethyl starch; Microsphere; Poly(lactide co glycolide); Protein

Indexed keywords

BOVINE SERUM ALBUMIN; HORSERADISH PEROXIDASE; MICROSPHERE; POLY(ACRYLOYL HYDROXYETHYL STARCH); POLYGLACTIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED RELEASE FORMULATION; ENZYME ACTIVITY; EVAPORATION; GEL PERMEATION CHROMATOGRAPHY; HYDROGEL; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN STABILITY; SCANNING ELECTRON MICROSCOPY;

ACRYLIC RESINS; CHEMISTRY, PHYSICAL; DRUG COMPOUNDING; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HORSERADISH PEROXIDASE; HYDROGEL; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; PROTEINS; SERUM ALBUMIN, BOVINE; STARCH; VINYL COMPOUNDS;

EID: 0034748324     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013090700443     Document Type: Article

References (23)

1. Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery
2. A novel in vitro release technique for peptide-containing biodegradable microspheres
3. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate
4. Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs
5. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery
6. Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres
7. Effect of processing parameters on the properties of peptide-containing PLGA
8. Polylactide microparticles prepared by double emulsion-evaporation. II. Effect of poly(lactide-co-glycolide) composition on the stability of the primary and secondary emulsions
9. Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres
10. Protein instability toward organic solvent/water emulsification: Implications for protein microencapsulation into microspheres
11. The stability of recombinant human growth hormone in poly(lactide-co-glycolide acid) (PLGA) microspheres
12. Protein release from poly(lactide-co-glycolide acid) microspheres: Protein stability problems
13. pH and osmotic pressure inside biodegradable microspheres during erosion
14. Protein delivery from poly(lactide-co-glycolide acid) biodegradable microspheres: Release kinetics and stability issues
15. NGF release from poly(d,l-lactide-co-glycolide) microspheres: Effect of some oof formulation parameters on encapsulated NGF stability
16. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres
17. Protein loaded biodegradable microspheres based on PLGA-protein bioconjugates
18. Blends of PVA and PLGA: Control of permeability and degradability of hydrogels by blending
19. A novel approach to stabilization of protein drugs in poly(lactide-co-glycolide) microspheres using agarose hydrogel
20. A heterogeneous structured composite based on poly(lactide-co-glycolide acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery
21. A novel biodegradable system based on gelatin nanoparticle and poly(lactide-co-glycolide acid) mlcrospheres for protein and peptide delivery
22. Evaluation of a statistical model for the formation of poly[acryloyl hydroxyethyl starch] microspheres
23. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4